Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:18:57 EDT Thu 30 Mar 2023
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Z:ABBV - ABBVIE INC - http://www.abbvie.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ABBV - Z157.92-0.08-0.13,635.8570,92725,311158.01  158.53  157.42175.91  134.0919:49:57Mar 2915 min RT 2¢

Recent Trades - Last 10 of 25311
Time ETExPriceChangeVolume
19:49:57Z157.80-0.204
19:00:21Z157.81-0.197
18:58:32Z157.81-0.192
18:37:20Z157.91-0.0933
18:26:10Z157.91-0.095
17:51:23Z157.80-0.20100
17:31:12Z157.91-0.092
17:26:28Z157.90-0.105
17:16:32Z157.90-0.101
17:06:54Z157.92-0.08241,049

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2023-03-29 09:00U:ABBVNews ReleaseAllergan Aesthetics* to showcase 360 ‚ ° approach to clinical practice, aesthetic products, and patients with expert-led symposia at AMWC 2023
2023-03-23 09:00U:ABBVNews ReleaseAbbVie Advances Upadacitinib (RINVOQ ‚ ®) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus
2023-03-23 08:30U:ABBVNews ReleaseRisankizumab (SKYRIZI ‚ ®) Achieves Primary and All Secondary Endpoints in Phase 3 Induction Study in Patients With Ulcerative Colitis
2023-03-22 08:45U:ABBVNews ReleaseAbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application
2023-03-18 10:03U:ABBVNews ReleaseAbbVie Announces Late-Breaking Results of Study Evaluating 52-Week Efficacy and Safety of SKYRIZI ‚ ® (risankizumab) in Plaque Psoriasis Patients With a Prior Suboptimal Response to IL-17 Inhibitor Therapy
2023-03-15 08:03U:ABBVNews ReleaseAbbVie Partners with Award-Winning Redglass Pictures on New Film Shedding Light on the Hidden Struggles of Those Living with Eczema
2023-03-13 08:03U:ABBVNews ReleaseAbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting
2023-03-08 08:45U:ABBVNews ReleaseBOTOX ‚ ® Cosmetic (onabotulinumtoxinA) Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs
2023-03-08 08:00U:ABBVNews ReleaseAbbVie to Present at the Barclays Global Healthcare Conference